Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,342,964
+$59,352 QoQ
Shares Held
14,950
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#394
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Ellis Asset Management LLC holds $17,156,761 across 7 Drug Manufacturers - General names. NVS ranks #4 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,547 | $4,254,378 | |
| 2 | SNY |
Sanofi
|
81,342 | $3,470,049 | |
| 3 | JNJ |
Johnson & Johnson
|
13,294 | $3,376,277 | |
| 4 | NVS |
Novartis AG
This page
|
14,950 | $2,342,964 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,988 | $1,925,958 | |
| 6 | ABBV |
AbbVie Inc.
|
6,083 | $1,530,726 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,450 | $256,409 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,342,964 | 14,950 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,283,612 | 14,950 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,102,517 | 15,250 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,886,538 | 14,711 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,762,026 | 14,561 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,378,004 | 12,361 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,102,230 | 11,327 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,366,897 | 11,884 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,278,478 | 12,009 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,177,107 | 12,169 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,289,285 | 12,769 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,300,650 | 12,769 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,313,747 | 13,019 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,206,948 | 13,119 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,235,515 | 13,619 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,044,529 | 13,742 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,174,544 | 13,895 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,217,004 | 13,869 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,204,374 | 13,769 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,147,291 | 14,029 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,323,709 | 14,508 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,522,313 | 17,809 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,768,579 | 18,729 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,644,326 | 18,909 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,684,875 | 19,291 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,627,645 | 19,741 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||